Creator
Mia Malan is Bhekisisa's editor-in-chief and executive director. Malan has won more than 20 African journalism awards for her work and is a former fellow of the Reuters Institute for the Study of Journalism at Oxford University.
The International Aids Conference in Rio de Janeiro highlighted a stark reality: the era of Aids exceptionalism is ending amid unprecedented funding cuts. As science delivers…
South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent's roughly 60,000 users are in the…
For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…
South Africa faces a surge in illegal weight-loss drugs, as expensive GLP-1 medicines drive a black market for cheaper, untested versions. This trend raises serious health…
Amid rising anti-immigrant sentiment and violence in South Africa, a clause in the National Health Insurance (NHI) Act threatens to deny HIV treatment to refugees, asylum…
The six-monthly anti-HIV jab, which prevents HIV through sex, is now stocked for free at 360 government clinics in six of South Africa’s provinces. How does the jab work, how do…
The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a…
Experts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where…
SA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches…
Health Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk…
South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by…
At 33, the retired Constitutional Court justice thought he had, maybe, seven years left. His story traces the arc from certain death because of Aids to a chronic, manageable…
A review of 37 studies found that when people stop taking weight-loss drugs like Ozempic, the weight comes back
After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities are settling in
For some teenagers, emotional pain manifests as deliberately cutting, burning, hitting, biting, scratching or picking at their skin
The judgment complements a November ruling meant to stop groups such as Operation Dudula from blocking foreign nationals from entering government hospitals and clinics and…
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
While groups like Operation Dudula flood the zone with fear, confusion and misinformation around healthcare access for foreign nationals, that space has been easy to muddy,…
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex
